LB Pharmaceuticals Inc Common Stock (LBRX) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
LBRX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LBRX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export LBRX earnings history in CSV or JSON format
Free sign-in required to download data
LB Pharmaceuticals Inc Common Stock (LBRX) Earnings Overview
As of May 8, 2026, LB Pharmaceuticals Inc Common Stock (LBRX) reported trailing twelve-month net income of -$30M, reflecting -907.3% year-over-year growth. The company earned $-1.18 per diluted share over the past four quarters.
Looking at the long-term picture, LBRX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2023.
LB Pharmaceuticals Inc Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SAVA (-$106M net income), ATHA (-$129M net income), INVA ($504M net income, 63.8% margin), LBRX has comparable earnings metrics. Compare LBRX vs SAVA →
LBRX Earnings vs Peers
Earnings metrics vs comparable public companies
LBRX Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$63M | -905.6% | -$65M | $-17.83 | - | - |
| 2023 | -$6M | +56.3% | -$11M | $-1.77 | - | - |
| 2022 | -$14M | - | -$3M | $-4.05 | - | - |
See LBRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LBRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LBRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLBRX — Frequently Asked Questions
Quick answers to the most common questions about buying LBRX stock.
Is LBRX growing earnings?
LBRX EPS fell to $-1.18, with earnings declining -907.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-30M.
What are LBRX's profit margins?
LB Pharmaceuticals Inc Common Stock net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are LBRX's earnings?
LBRX earnings data spans 2022-2024. The declining earnings trend is -907.3% YoY. Historical data enables comparison across business cycles.